Horizon Discovery

PerkinElmer snaps up CRISPR provider Horizon Discovery for $383M

PerkinElmer has moved to expand its life sciences portfolio with CRISPR and gene editing offerings by snapping up the cell engineer Horizon Discovery.

Conor Hale Nov 2, 2020 10:49am

Horizon Discovery collaborating with AstraZeneca on gene editing

Sep 19, 2018 9:55am

Abcam ends pursuit of £270M Horizon Discovery buyout

May 9, 2018 8:51am

Horizon Discovery rejects Abcam’s £270M buyout bid

May 3, 2018 6:00am

Roche taps Horizon for NTRK cancer assay support

Dec 18, 2017 4:56am

Oxford Genetics licenses CRISPR tech to power synbio push

May 10, 2017 7:20am